Business Description
Ono Pharmaceutical, founded in 1717 and based in Osaka, Japan, is a global drug maker with a broad portfolio spanning cancer treatments, diabetes management, heart conditions, neurological disorders, and autoimmune diseases. The company markets well-known therapies such as Opdivo for malignant tumors, Forxiga for diabetes and heart failure, and Orencia for rheumatoid arthritis, among many others sold worldwide. Ono also maintains an active research pipeline targeting dozens of serious conditions, supported by partnerships with institutions including Harvard University and several biotechnology firms.
